Who is sponsoring NCT01668862?

NCT01668862 is sponsored by Kasiak Research Pvt. Ltd..

What condition does NCT01668862 study?

NCT01668862 studies Lateral Epicondylitis (Tennis Elbow).

What drugs are being tested in NCT01668862?

Interventions: Autologous Human Platelet Lysate, Corticosteroid.

What is the status of NCT01668862?

NCT01668862 is currently UNKNOWN.

Last reviewed 2012-08-16 · How we verify

A Prospective, Multicentric, Open Label, Randomised, Bio-Interventional Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For The Treatment Of Lateral Epicondylitis (Tennis Elbow)

NCT01668862 Phase 1/Phase 2 UNKNOWN

This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of human Platelet Lysate (HPL) in subjects with Lateral Epicondylitis (Tennis Elbow). The study is being conducted in 2 centers in India. The primary end points are Visual Analog Score (VAS) and Patient rated tennis elbow evaluation (PRTEE) score. The secondary endpoint is improvement in ultrasonography form randomization to End of study.

Details

Lead sponsor	Kasiak Research Pvt. Ltd.
Phase	Phase 1/Phase 2
Status	UNKNOWN
Enrolment	20
Start date	2012-03
Completion	2012-11

Conditions

Lateral Epicondylitis (Tennis Elbow)

Interventions

Autologous Human Platelet Lysate
Corticosteroid

Primary outcomes

Change in Visual Analog Score (VAS) — Day 0, Month 1, Month 2, End of Study - Month 3

Countries

India